Lyon
France
79
2026-01-29
33
2025-09-23
These are the the leading inventors for applications assigned to ADOCIA:
ADOCIA based in Lyon, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
HYDROGELS FOR CELL THERAPY
#2 | 2025-03-27THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN
#3 | 2025-03-20COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID
#4 | 2024-04-11COMPOSITIONS COMPRISING AT LEAST AN INSULIN AND AN AMYLIN RECEPTOR AGONIST FOR TREATING DIABETES, IN A PATIENT/PERSON HAVING A BMI OF MORE THAN 28 KG/M² AND/OR AN HBA1C OF MORE THAN 7.6%
#5 | 2023-07-06PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION
#6 | 2023-06-29PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION
#7 | 2023-03-02COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST
#8 | 2022-12-29COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID
#9 | 2022-07-14 ✅ Patent 12,421,327 granted on 2025-09-23HYDROGELS FOR CELL THERAPY
#10 | 2022-02-10INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST A BASAL INSULIN WHICH PI IS COMPRISED BETWEEN 5.8 AND 8.5 AND A COPOLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#11 | 2021-12-30 ✅ Patent 12,186,373 granted on 2025-01-07Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
#12 | 2021-12-16COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID
#13 | 2021-10-14THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN
#14 | 2021-08-12COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND AN AMPHOIPHILIC COMPOUNDS CONTAINING HYDRIPHOBIC RADICALS
#15 | 2021-07-08PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN OF WHICH THE PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL
#16 | 2020-12-31 ✅ Patent 11,576,952 granted on 2023-02-14Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#17 | 2020-10-01 ✅ Patent 11,883,496 granted on 2024-01-30Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#18 | 2020-10-01COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID
#19 | 2020-06-18 ✅ Patent 11,065,305 granted on 2021-07-20Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#20 | 2020-06-11INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHICH PI IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO-ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS AND A LIMITED AMOUNT OF M-CRESOL
#21 | 2020-02-13 ✅ Patent 11,707,507 granted on 2023-07-25Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
#22 | 2019-12-26INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE PI OF WHICH IS FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#23 | 2019-10-31 ✅ Patent 11,129,877 granted on 2021-09-28Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
#24 | 2019-09-12 ✅ Patent 10,987,426 granted on 2021-04-27Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#25 | 2019-09-12 ✅ Patent 11,633,460 granted on 2023-04-25Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#26 | 2019-09-12COMPOSITIONS IN THE FORM OF AN INJECTALE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID
#27 | 2019-09-12 ✅ Patent 11,191,812 granted on 2021-12-07Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#28 | 2019-09-12COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID
#29 | 2019-09-12 ✅ Patent 11,173,109 granted on 2021-11-16Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
#30 | 2019-09-12PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASIC INSULIN WITH A PI COMPRISED FROM 5.8 TO 8.5 AND A CO-POLYAMINOACIDE BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#31 | 2019-07-18INJECTABLE PH 7 SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN HAVING A PI FROM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#32 | 2019-02-21 ✅ Patent 10,610,572 granted on 2020-04-07Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#33 | 2018-08-23INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#34 | 2018-08-23FAST-ACTING INSULIN COMPOSITION COMPRISING A CITRIC ACID SALT
#35 | 2018-07-12 ✅ Patent 10,463,717 granted on 2019-11-05Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
#36 | 2018-06-21 ✅ Patent 10,449,256 granted on 2019-10-22Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
#37 | 2018-05-03STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN
#38 | 2017-12-28 ✅ Patent 10,583,175 granted on 2020-03-10Rapid-acting insulin formulation comprising a substituted anionic compound
#39 | 2017-12-07 ✅ Patent 10,383,920 granted on 2019-08-20Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#40 | 2017-12-07 ✅ Patent 10,548,952 granted on 2020-02-04Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#41 | 2017-12-07 ✅ Patent 10,485,851 granted on 2019-11-26Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
#42 | 2017-12-07 ✅ Patent 10,383,918 granted on 2019-08-20Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid
#43 | 2017-06-29INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
#44 | 2017-05-25SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS
#45 | 2017-05-18 ✅ Patent 10,792,335 granted on 2020-10-06Rapid-acting insulin composition comprising a substituted citrate
#46 | 2015-09-10INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
#47 | 2015-08-20 ✅ Patent 9,492,467 granted on 2016-11-15Rapid-acting insulin formulation comprising an oligosaccharide
#48 | 2014-08-21INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#49 | 2013-09-19POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE
#50 | 2013-09-05Rapid acting insulin formulation comprising an oligosaccharide
#51 | 2013-07-11 ✅ Patent 9,198,971 granted on 2015-12-01Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid
#52 | 2013-03-14 ✅ Patent 9,089,476 granted on 2015-07-28Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5
#53 | 2012-12-06 ✅ Patent 9,018,190 granted on 2015-04-28Functionalized oligosaccharides
#54 | 2012-11-22Polysaccharides having an adjustable degree of functionalization
#55 | 2012-04-19Fast-acting insulin formulation
#56 | 2012-02-16DEXTRAN FUNCTIONALIZED BY HYDROPHOBIC AMINO ACIDS
#57 | 2011-12-08 ✅ Patent 8,241,620 granted on 2012-08-14Complex polymere amphiphile-PDGF
#58 | 2011-08-11 ✅ Patent 9,115,218 granted on 2015-08-25Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer
#59 | 2011-07-21Polysaccharide/BMP complexes which are soluble at physiological pH
#60 | 2011-07-14 ✅ Patent 9,493,583 granted on 2016-11-15Anionic polysaccharides functionalized by a hydrophobic acid derivative
#61 | 2011-06-30Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support
#62 | 2011-05-12Polysaccharides comprising carboxyl functional groups substituted via esterification by a hydrophobic alcohol
#63 | 2011-02-03Nouvelle forme d'administration de proteines osteogeniques
#64 | 2011-01-20Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
#65 | 2010-12-02 ✅ Patent 8,426,382 granted on 2013-04-23Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
#66 | 2010-09-30 ✅ Patent 8,669,227 granted on 2014-03-11Fast-acting insulin formulation
#67 | 2010-07-29Angiogenic composition
#68 | 2010-07-22 ✅ Patent 8,367,640 granted on 2013-02-05Complex consisted of a polysaccharide and an HBP
#69 | 2010-07-01Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
#70 | 2010-07-01Complex between human insulin and an amphiphilic polymer and use of this complex in the preparation of a fast-acting human insulin formulation
#71 | 2010-07-01 ✅ Patent 8,497,253 granted on 2013-07-30Administration form of osteogenic protein complexes
#72 | 2010-06-03Polysaccharides functionalized by tryptophan derivatives
#73 | 2010-01-14Osteogenic synergic composition
#74 | 2009-12-10Anionic polyamide functionalized with a tryptophan unit
#75 | 2009-11-26OSTEOGENIC COMPOSITION COMPRISING A GROWTH FACTOR/AMPHIPHILIC POLYMER COMPLEX, A SOLUBLE CATION SALT AND AN ORGANIC SUPPORT
#76 | 2009-11-26Osteogenic composition comprising a growth factor, a soluble cation salt and organic support
#77 | 2009-02-19 ✅ Patent 8,389,661 granted on 2013-03-05Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs
#78 | 2008-11-27Angiogenic composition
#79 | 2008-09-25 ✅ Patent 8,629,124 granted on 2014-01-14Dextran functionalized by hydrophobic amino acids
Also check out ADOCIA's (Lyon, France) applicant profile with 6 patent applications submitted.
13892 ⎘